Search Results - Bezverbnaya, K

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Optimizing the culture process of engineered t cells to favor long-term efficacy following adoptive immunotherapy

    Optimizing the culture process of engineered t cells to favor long-term efficacy following adoptive immunotherapy by Carli, C, Khuon, M, Dahmani, A, Bezverbnaya, K, Bramson, J, Delisle, J

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    BCMA-specific TAC receptor-engineered T cells for multiple myeloma

    BCMA-specific TAC receptor-engineered T cells for multiple myeloma by Bezverbnaya, K, Lau, V, Aarts, C, Denisova, G, Afsahi, A, Cummings, D, Helsen, C.W, Bramson, J

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity

    T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity by Helsen, C.W, Hammill, J, Mwawasi, K, Lau, V, Hayes, D, Afsahi, A, Bezverbnaya, K, Newhook, L, Aarts, C, Denisova, G, Bramson, J

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Non-toxic cross-reactivity with healthy tissues supports in vivo expansion and therapeutic efficacy of T cells engineered with synthetic antigen receptors

    Non-toxic cross-reactivity with healthy tissues supports in vivo expansion and therapeutic efficacy of T cells engineered with synthetic antigen receptors by Bezverbnaya, K., Baker, C.L., Aarts, C., Cummings, D., Denisova, G., Bramson, J.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    301 - Optimizing the culture process of engineered t cells to favor long-term efficacy following adoptive immunotherapy

    301 - Optimizing the culture process of engineered t cells to favor long-term efficacy following adoptive immunotherapy by Carli, C., Khuon, M., Dahmani, A., Bezverbnaya, K., Bramson, J., Delisle, J.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    6 - BCMA-specific TAC receptor-engineered T cells for multiple myeloma

    6 - BCMA-specific TAC receptor-engineered T cells for multiple myeloma by Bezverbnaya, K., Lau, V., Aarts, C., Denisova, G., Afsahi, A., Cummings, D., Helsen, C.W., Bramson, J.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    4 - T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity

    4 - T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity by Helsen, C.W., Hammill, J., Mwawasi, K., Lau, V., Hayes, D., Afsahi, A., Bezverbnaya, K., Newhook, L., Aarts, C., Denisova, G., Bramson, J.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Evaluation of Sea Water Quality in the Coastal Zone of Primor'e Using the Method of Microbial Indication

    Evaluation of Sea Water Quality in the Coastal Zone of Primor'e Using the Method of Microbial Indication by Bezverbnaya, I P, Dimitrieva, G Yu, Tazaki, K, Vatanabe, H

    Published in Water resources
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Reduction of nitrobenzene with 1,3-dihydroorganodisilazanes

    Reduction of nitrobenzene with 1,3-dihydroorganodisilazanes by Andrianov, K. A., Tartakovskaya, L. M., Sidorov, V. I., Bezverbnaya, T. F.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: